| Authors | Roland B Walter, Megan Othus, Kaysey F Orlowski, Emily N McDaniel, Bart L Scott, Pamela S Becker, Mary-Elizabeth M Percival, Paul C Hendrie, Bruno C Medeiros, Michael T Chiarella, Arthur C Louie, Elihu H Estey |
| Journal | Haematologica
(Haematologica)
Vol. 103
Issue 3
Pg. e106-e109
(03 2018)
ISSN: 1592-8721 [Electronic] Italy |
| PMID | 29242304
(Publication Type: Clinical Trial, Phase II, Letter, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- CPX-351
- Cytarabine
- Daunorubicin
|
| Topics |
- Adult
- Aged
- Aged, 80 and over
- Cytarabine
(administration & dosage)
- Daunorubicin
(administration & dosage)
- Female
- Humans
- Leukemia, Myeloid
(drug therapy, mortality)
- Leukemia, Myeloid, Acute
(drug therapy, mortality)
- Male
- Middle Aged
- Physical Fitness
- Survival Analysis
- Treatment Outcome
|
